PL361617A1 - Nowe zastosowanie kombinacji agonistów 5-HT1A i selektywnych inhibitorów wychwytu zwrotnego serotoniny - Google Patents

Nowe zastosowanie kombinacji agonistów 5-HT1A i selektywnych inhibitorów wychwytu zwrotnego serotoniny

Info

Publication number
PL361617A1
PL361617A1 PL36161701A PL36161701A PL361617A1 PL 361617 A1 PL361617 A1 PL 361617A1 PL 36161701 A PL36161701 A PL 36161701A PL 36161701 A PL36161701 A PL 36161701A PL 361617 A1 PL361617 A1 PL 361617A1
Authority
PL
Poland
Prior art keywords
agonists
combined
serotonin reuptake
reuptake inhibitors
selective serotonin
Prior art date
Application number
PL36161701A
Other languages
English (en)
Inventor
Gerd Bartoszyk
Ewen Sedman
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of PL361617A1 publication Critical patent/PL361617A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
PL36161701A 2000-11-20 2001-11-02 Nowe zastosowanie kombinacji agonistów 5-HT1A i selektywnych inhibitorów wychwytu zwrotnego serotoniny PL361617A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00125409 2000-11-20
PCT/EP2001/012686 WO2002039989A1 (en) 2000-11-20 2001-11-02 Novel use of combined 5-ht1a agonists and selective serotonin reuptake inhibitors

Publications (1)

Publication Number Publication Date
PL361617A1 true PL361617A1 (pl) 2004-10-04

Family

ID=8170432

Family Applications (1)

Application Number Title Priority Date Filing Date
PL36161701A PL361617A1 (pl) 2000-11-20 2001-11-02 Nowe zastosowanie kombinacji agonistów 5-HT1A i selektywnych inhibitorów wychwytu zwrotnego serotoniny

Country Status (19)

Country Link
US (1) US7479492B2 (pl)
EP (1) EP1335716A1 (pl)
JP (1) JP2004513916A (pl)
KR (1) KR20030048477A (pl)
CN (1) CN1541093A (pl)
AR (1) AR031463A1 (pl)
AU (2) AU2180302A (pl)
BR (1) BR0115434A (pl)
CA (1) CA2429216C (pl)
CZ (1) CZ20031448A3 (pl)
HU (1) HUP0400504A3 (pl)
MX (1) MXPA03004341A (pl)
NO (1) NO20032248D0 (pl)
PL (1) PL361617A1 (pl)
RU (1) RU2302243C2 (pl)
SK (1) SK6442003A3 (pl)
UA (1) UA76130C2 (pl)
WO (1) WO2002039989A1 (pl)
ZA (1) ZA200304757B (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10326939A1 (de) * 2003-06-16 2005-01-05 Merck Patent Gmbh Indol-Derivate
WO2005094896A2 (en) * 2004-03-26 2005-10-13 Baylor University Targeted serotonin reuptake inhibitors
WO2006006152A2 (en) * 2004-07-08 2006-01-19 Ramot At Tel-Aviv University Ltd Treatment of disorders and diseases of the colon
US7994331B2 (en) 2005-07-13 2011-08-09 Msd K.K. Heterocycle-substituted benzimidazole derivative
PL2044043T5 (pl) 2006-06-16 2022-05-02 H. Lundbeck A/S Bromowodorek 1-[2-(2,4-dimetylofenylosulfanylo)fenylo]piperazyny jako związek o połączonym działaniu wychwytu zwrotnego serotoniny i działaniu na 5-ht3 i 5-ht1a do leczenia upośledzenia funckji poznawczych
TW200848411A (en) * 2007-03-20 2008-12-16 Lundbeck & Co As H Novel therapeutic uses of 1-[2-(2, 4-dimethylphenylsulfanyl)phenyl]-piperazine

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2222768B (en) 1988-06-17 1992-01-22 Nat Res Dev Analgesic compounds and compositions
US5589511A (en) * 1990-08-13 1996-12-31 Sepracor Inc. Method for treating migraine headaches using optically pure S(+) fluoxetine
US5578612A (en) 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
US5434174A (en) 1992-07-17 1995-07-18 Eli Lilly And Company Isoxazole derivatives for the treatment of irritable bowel syndrome
DE4333254A1 (de) * 1993-09-30 1995-04-06 Merck Patent Gmbh Piperidine und Piperazine
US5576321A (en) 1995-01-17 1996-11-19 Eli Lilly And Company Compounds having effects on serotonin-related systems
DE19512639A1 (de) * 1995-04-05 1996-10-10 Merck Patent Gmbh Benzonitrile und -fluoride
US5912256A (en) * 1996-06-20 1999-06-15 Eli Lilly And Company Compounds having effects on serotonin-related systems
UA56185C2 (uk) 1996-09-30 2003-05-15 Пфайзер Інк. Аралкіл- та аралкіліденгетероциклічні лактами та іміди, фармацевтична композиція та спосіб лікування
GB9911863D0 (en) 1999-05-21 1999-07-21 Knoll Ag Therapeutic agents
TW518218B (en) * 1999-05-27 2003-01-21 Merck Patent Gmbh Pharmaceutical compositions comprising 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine or its physiologically acceptable salts for use in the treatment of sub-type anxiety disorders

Also Published As

Publication number Publication date
NO20032248L (no) 2003-05-19
ZA200304757B (en) 2004-09-20
RU2302243C2 (ru) 2007-07-10
CA2429216A1 (en) 2002-05-23
US7479492B2 (en) 2009-01-20
AU2002221803B2 (en) 2007-02-15
CA2429216C (en) 2012-08-07
CN1541093A (zh) 2004-10-27
NO20032248D0 (no) 2003-05-19
JP2004513916A (ja) 2004-05-13
UA76130C2 (en) 2006-07-17
MXPA03004341A (es) 2003-08-19
HUP0400504A3 (en) 2006-02-28
CZ20031448A3 (cs) 2003-09-17
BR0115434A (pt) 2003-10-07
HUP0400504A2 (hu) 2004-06-28
EP1335716A1 (en) 2003-08-20
US20040014771A1 (en) 2004-01-22
AR031463A1 (es) 2003-09-24
KR20030048477A (ko) 2003-06-19
SK6442003A3 (en) 2003-09-11
WO2002039989A1 (en) 2002-05-23
AU2180302A (en) 2002-05-27

Similar Documents

Publication Publication Date Title
PL366233A1 (pl) Podstawione pirydoindole jako agoniści i antagoniści serotoniny
IL147246A0 (en) Highly selective norepinephrine reuptake inhibitors and methods of using the same
PT1749818E (pt) Derivados de fenil-piperidina como inibidores da reabsorção da serotonina
HK1044905A1 (zh) 用選擇性復合胺再吸收抑制劑抑制血小板活化的方法
AU7191001A (en) Use of dopamine D<sub>2</sub>/D<sub>3</sub> receptor agonists to treat fibromyalgia
HUP0203586A3 (en) The combination of a serotonin reuptake inhibitor and a 5-ht2c antagonist, inverse agonist or partial agonist
SG60073A1 (en) Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors
MXPA03006260A (es) Derivados de amina sustituidos y metodos de uso.
HK1057214A1 (en) New mandelic acid derivatives and their use as throbin inhibitors
HUP0300371A3 (en) Tag library compounds, compositions, kits and methods of use
MXPA03008807A (es) Derivados de ciclopropilindol como inhibidores selectivos de recaptacion de serotonina.
GB0025782D0 (en) Use of inhibitors
PL364821A1 (pl) Nowe fenylopiperazyny
MXPA03000694A (es) Nuevo uso de los inhibidores de lipasa.
IL154343A0 (en) Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors
EE200000141A (et) 5-HT tagasihaarde inhibiitori kombinatsioon h5-HT 1B antagonisti või osalise agonistiga
AU1502702A (en) Novel uses of combined 5-HT<sub>1A</sub> agonists and serotonin reuptake inhibitors
PL361617A1 (pl) Nowe zastosowanie kombinacji agonistów 5-HT1A i selektywnych inhibitorów wychwytu zwrotnego serotoniny
HUP0303880A2 (hu) Fenil-heterociklil-éter-származékok mint szerotonin-újrafelvétel-inhibitorok, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
PL351301A1 (en) Novel inhibitors of metaloprotease, methods of obtaining them and pharmacological composition containing such inhibitors
EP1028958A4 (en) ARYLPIPERAZINES ACTING AS SEROTONIN REABSORPTION INHIBITORS AND AS 5-HT1D ALPHA ANTAGONISTS
HUP0204376A3 (en) Novel invertase inhibitors and methods of use
SI1237553T1 (sl) Kombinacija inhibitorja ponovnega navzema serotonina in antagonista 5-ht 2c?, inverznega agonista ali delnega agonista
AU1212002A (en) Use of lipase inhibitors
HK1053059A1 (zh) 新用途

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)